| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S11908-018-0641-X |
| P698 | PubMed publication ID | 29959591 |
| P2093 | author name string | Ari Bitnun | |
| E Ann Yeh | |||
| E. Ann Yeh | |||
| P2860 | cites work | Histological studies of Cox-sackie A7 poliomyelitis in man and monkeys | Q79401166 |
| Outcome of enterovirus 71 infections with or without stage-based management: 1998 to 2002 | Q79892365 | ||
| Clinical aspects of acute poliomyelitis | Q80335992 | ||
| A fatal central nervous system enterovirus 68 infection | Q84242096 | ||
| Surveillance summary of hospitalized pediatric enterovirus D68 cases in Canada, September 2014 | Q91239795 | ||
| Epidemics to eradication: the modern history of poliomyelitis | Q21245132 | ||
| A study of the neurological disorder associated with acute haemorrhagic conjunctivitis due to enterovirus 70. | Q24515357 | ||
| Vaccine-associated paralytic poliomyelitis: a review of the epidemiology and estimation of the global burden | Q26992253 | ||
| Severe tick borne encephalitis with simultaneous brain stem, bithalamic, and spinal cord involvement documented by MRI | Q27477871 | ||
| Identification and validation of clinical predictors for the risk of neurological involvement in children with hand, foot, and mouth disease in Sarawak | Q27487876 | ||
| Scavenger receptor B2 is a cellular receptor for enterovirus 71 | Q28249350 | ||
| Enterovirus 71 infection and vaccines | Q30238518 | ||
| Acute Flaccid Paralysis Associated with Novel Enterovirus C105. | Q30370514 | ||
| Lumbosacral radiculomyelitis associated with pandemic acute haemorrhagic conjunctivitis | Q30407501 | ||
| In vitro antiviral activity and single-dose pharmacokinetics in humans of a novel, orally bioavailable inhibitor of human rhinovirus 3C protease | Q30448335 | ||
| Conservation of amino acids in human rhinovirus 3C protease correlates with broad-spectrum antiviral activity of rupintrivir, a novel human rhinovirus 3C protease inhibitor. | Q30448643 | ||
| Phase II, randomized, double-blind, placebo-controlled studies of ruprintrivir nasal spray 2-percent suspension for prevention and treatment of experimentally induced rhinovirus colds in healthy volunteers | Q30451184 | ||
| Receptor-dependent and -independent axonal retrograde transport of poliovirus in motor neurons | Q30487625 | ||
| Sentinel surveillance for human enterovirus 71 in Sarawak, Malaysia: lessons from the first 7 years | Q33249309 | ||
| Antiviral Activity of Pocapavir in a Randomized, Blinded, Placebo-Controlled Human Oral Poliovirus Vaccine Challenge Model | Q33568783 | ||
| Genetic changes found in a distinct clade of Enterovirus D68 associated with paralysis during the 2014 outbreak. | Q33660302 | ||
| Identification and molecular characterization of non-polio enteroviruses from children with acute flaccid paralysis in West Africa, 2013-2014 | Q33812693 | ||
| An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group. | Q33875086 | ||
| Neurologic complications in children with enterovirus 71 infection | Q33875092 | ||
| Non-polio enteroviruses from acute flaccid paralysis surveillance in Shandong Province, China, 1988-2013 | Q34077015 | ||
| The association between acute flaccid myelitis (AFM) and Enterovirus D68 (EV-D68) - what is the evidence for causation? | Q47547524 | ||
| Enterovirus D68 virus-like particles expressed in Pichia pastoris potently induce neutralizing antibody responses and confer protection against lethal viral infection in mice | Q47555463 | ||
| Electrodiagnostic findings in acute flaccid myelitis related to enterovirus D68. | Q48171461 | ||
| Complete sequence analyses of enterovirus 71 strains from fatal and non-fatal cases of the hand, foot and mouth disease outbreak in Singapore (2000). | Q48266466 | ||
| Fatal enterovirus 71 encephalomyelitis | Q48335107 | ||
| Modulation of cytokine production by intravenous immunoglobulin in patients with enterovirus 71-associated brainstem encephalitis | Q48464853 | ||
| Neuropathology in 2 cases of fatal enterovirus type 71 infection from a recent epidemic in the People's Republic of China: a histopathologic, immunohistochemical, and reverse transcription polymerase chain reaction study | Q48649556 | ||
| Acute flaccid paralysis in infants and young children with enterovirus 71 infection: MR imaging findings and clinical correlates. | Q54032951 | ||
| Type 1 wild poliovirus and putative enterovirus 109 in an outbreak of acute flaccid paralysis in Congo, October-November 2010. | Q54120963 | ||
| HLA-A33 is associated with susceptibility to enterovirus 71 infection. | Q54505115 | ||
| Genetic diversity of enterovirus 71 associated with hand, foot and mouth disease epidemics in Japan from 1983 to 2003. | Q54590135 | ||
| A comparison of the clinical features of poliomyelitis in adults and in children. | Q55038131 | ||
| Histopathologic basis of clinical findings in poliomyelitis. | Q55047033 | ||
| Bulbar poliomyelitis; its mechanism and treatment. | Q55047042 | ||
| Outbreak of neurologic enterovirus type 71 disease: a diagnostic challenge | Q57101093 | ||
| MRI of Enterovirus 71 myelitis with monoplegia | Q57107437 | ||
| Intramuscular injections within 30 days of immunization with oral poliovirus vaccine--a risk factor for vaccine-associated paralytic poliomyelitis | Q64135116 | ||
| Novel serotypes 105 and 116 are members of distinct subgroups of human enterovirus C | Q64360262 | ||
| Outbreak of poliomyelitis-like paralysis associated with enterovirus 71 | Q69761018 | ||
| A probable new human picornavirus associated with respiratory diseases | Q69992537 | ||
| MRI in acute poliomyelitis | Q71340879 | ||
| Paralytic poliomyelitis and nonpolio enteroviruses: studies in Scotland | Q71407448 | ||
| Polio-like motor paralysis associated with acute hemorrhagic conjunctivitis in an outbreak in 1981 in Bombay, India: clinical and serologic studies | Q71710544 | ||
| Electrophysiology of acute polio revisited. Utilizing newer EMG techniques in vaccine-associated disease | Q71879085 | ||
| Poliomyelitis: hyperintensity of the anterior horn cells on MR images of the spinal cord | Q72925753 | ||
| Poliomyelitic-like illness in central European encephalitis | Q74047774 | ||
| Duration of enterovirus shedding in stool | Q74630164 | ||
| THE CUTTER INCIDENT. POLIOMYELITIS FOLLOWING FORMALDEHYDE- INACTIVATED POLIOVIRUS VACCINATION IN THE UNITED STATES DURING THE SPRING OF 1955. I. BACKGROUND | Q76499936 | ||
| Immunohistochemical detection of infected neurons as a rapid diagnosis of enterovirus 71 encephalomyelitis | Q78170893 | ||
| Clinical features, diagnosis, and management of enterovirus 71. | Q34144978 | ||
| Differential diagnosis of acute flaccid paralysis and its role in poliomyelitis surveillance | Q34162005 | ||
| Frequent importation of enterovirus 71 from surrounding countries into the local community of Yamagata, Japan, between 1998 and 2003. | Q34231826 | ||
| Fluoxetine is a potent inhibitor of coxsackievirus replication | Q34323429 | ||
| Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial | Q34347924 | ||
| Ribavirin reduces mortality in enterovirus 71-infected mice by decreasing viral replication | Q34750642 | ||
| Nonpolioviruses and paralytic disease | Q35047340 | ||
| Global reemergence of enterovirus D68 as an important pathogen for acute respiratory infections | Q35532459 | ||
| West Nile Virus-associated flaccid paralysis outcome | Q35793924 | ||
| Evaluation of different clinical sample types in diagnosis of human enterovirus 71-associated hand-foot-and-mouth disease. | Q35913835 | ||
| West Nile virus-associated flaccid paralysis | Q36021961 | ||
| Epidemiologic and virologic investigation of hand, foot, and mouth disease, southern Vietnam, 2005. | Q36034012 | ||
| Treatment of Chronic Enterovirus Encephalitis With Fluoxetine in a Patient With X-Linked Agammaglobulinemia. | Q36136609 | ||
| Type A7 Coxsackie (type 4 poliomyelitis) virus infection in Scotland | Q36258863 | ||
| A mouse model of paralytic myelitis caused by enterovirus D68. | Q36288399 | ||
| Worldwide emergence of multiple clades of enterovirus 68. | Q36524001 | ||
| Enteroviruses in the early 21st century: new manifestations and challenges | Q36571245 | ||
| A Randomized, Double-Blind, Placebo-Controlled Trial of Pleconaril for the Treatment of Neonates With Enterovirus Sepsis | Q36612928 | ||
| Neurologic Manifestations of Enterovirus 71 Infection in Korea | Q36735837 | ||
| Selective serotonin reuptake inhibitor fluoxetine inhibits replication of human enteroviruses B and D by targeting viral protein 2C. | Q36757571 | ||
| Basic rationale, current methods and future directions for molecular typing of human enterovirus | Q36874351 | ||
| Rationale for the evaluation of fluoxetine in the treatment of enterovirus D68-associated acute flaccid myelitis | Q37378440 | ||
| Acute flaccid myelitis: A clinical review of US cases 2012-2015. | Q37397515 | ||
| Susceptibilities of enterovirus D68, enterovirus 71, and rhinovirus 87 strains to various antiviral compounds | Q37401695 | ||
| Virology, epidemiology, pathogenesis, and control of enterovirus 71. | Q37801742 | ||
| Enterovirus d68. A focused review and clinical highlights from the 2014 U.S. Outbreak | Q38365133 | ||
| Understanding Enterovirus 71 Neuropathogenesis and Its Impact on Other Neurotropic Enteroviruses | Q38567118 | ||
| Characterization of group B coxsackieviruses isolated from non-polio acute flaccid paralysis patients in Pakistan: vital assessment before polio eradication. | Q38664216 | ||
| Global emergence of enterovirus D68: a systematic review | Q38756005 | ||
| Enterovirus D68 and Human Respiratory Infections | Q38917023 | ||
| Clinical Course of Enterovirus D68 in Hospitalized Children | Q38967273 | ||
| Wild and vaccine-derived poliovirus circulation, and implications for polio eradication | Q39014586 | ||
| Acute Flaccid Myelitis in the United States, August-December 2014: Results of Nationwide Surveillance | Q39673099 | ||
| Non-polio enteroviruses in acute flaccid paralysis children of India: vital assessment before polio eradication | Q39951794 | ||
| Cost-effectiveness of a national enterovirus 71 vaccination program in China | Q40047717 | ||
| Clinical Characteristics and Functional Motor Outcomes of Enterovirus 71 Neurological Disease in Children. | Q40122082 | ||
| Acute Flaccid Myelitis of Unknown Etiology in California, 2012-2015. | Q40124669 | ||
| Clinical Analysis of 134 Children with Nervous System Damage Caused by Enterovirus 71 Infection | Q40161231 | ||
| Epidemiologic features of hand-foot-mouth disease and herpangina caused by enterovirus 71 in Taiwan, 1998-2005. | Q40187425 | ||
| Genetic polymorphism of CCL2-2510 and susceptibility to enterovirus 71 encephalitis in a Chinese population | Q40208529 | ||
| An inactivated enterovirus 71 vaccine in healthy children | Q40216677 | ||
| Longitudinal Outcomes in the 2014 Acute Flaccid Paralysis Cluster in Canada. | Q40334747 | ||
| Midbrain and spinal cord magnetic resonance imaging (MRI) changes in poliomyelitis | Q40366804 | ||
| 2-Year Efficacy, Immunogenicity, and Safety of Vigoo Enterovirus 71 Vaccine in Healthy Chinese Children: A Randomized Open-Label Study | Q40376000 | ||
| West Nile virus disease in children, United States, 1999-2007. | Q40388299 | ||
| ICAM-5/Telencephalin Is a Functional Entry Receptor for Enterovirus D68. | Q40421376 | ||
| Human enterovirus 71 disease in Sarawak, Malaysia: a prospective clinical, virological, and molecular epidemiological study. | Q40458463 | ||
| Asymmetric flaccid paralysis: a neuromuscular presentation of West Nile virus infection. | Q40557733 | ||
| Enterovirus and Human Parechovirus Surveillance - United States, 2009-2013. | Q40579943 | ||
| Deaths of children during an outbreak of hand, foot, and mouth disease in sarawak, malaysia: clinical and pathological characteristics of the disease. For the Outbreak Study Group | Q40614108 | ||
| Genetic analysis of enterovirus 71 isolated from fatal and non-fatal cases of hand, foot and mouth disease during an epidemic in Taiwan, 1998. | Q40858986 | ||
| Recognition and Management of Acute Flaccid Myelitis in Children | Q40888976 | ||
| Synergistic antiviral activity of gemcitabine and ribavirin against enteroviruses | Q40926272 | ||
| In Vitro Efficacy of Antiviral Compounds against Enterovirus D68. | Q41120057 | ||
| A novel outbreak enterovirus D68 strain associated with acute flaccid myelitis cases in the USA (2012-14): a retrospective cohort study. | Q41359548 | ||
| A cluster of acute flaccid paralysis and cranial nerve dysfunction temporally associated with an outbreak of enterovirus D68 in children in Colorado, USA. | Q41511681 | ||
| MRI findings in children with acute flaccid paralysis and cranial nerve dysfunction occurring during the 2014 enterovirus D68 outbreak | Q41653930 | ||
| Comparison of the detection rates of RT-PCR and virus culture using a combination of specimens from multiple sites for enterovirus-associated encephalomyelitis during enterovirus 71 epidemic. | Q41731530 | ||
| First use of investigational antiviral drug pocapavir (v-073) for treating neonatal enteroviral sepsis | Q41736295 | ||
| Genomic characterization of coxsackievirus type A24 strains associated with acute flaccid paralysis and rarely identified Hopkins syndrome | Q42202601 | ||
| Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China | Q42226974 | ||
| Enterovirus 71 infection-associated acute flaccid paralysis: a case series of long-term neurologic follow-up | Q42241768 | ||
| The distribution of inflammation and virus in human enterovirus 71 encephalomyelitis suggests possible viral spread by neural pathways | Q42524022 | ||
| An outbreak of enterovirus 71 infection in Taiwan 1998: a comprehensive pathological, virological, and molecular study on a case of fulminant encephalitis | Q42626570 | ||
| Rhombencephalitis and coxsackievirus A16 | Q42789435 | ||
| Clusters of acute respiratory illness associated with human enterovirus 68--Asia, Europe, and United States, 2008-2010. | Q43638920 | ||
| Rupintrivir is a promising candidate for treating severe cases of enterovirus-71 infection: evaluation of antiviral efficacy in a murine infection model | Q44103515 | ||
| Emergence and epidemic occurrence of enterovirus 68 respiratory infections in The Netherlands in 2010. | Q44644397 | ||
| Adult polio-like syndrome following Enterovirus 70 conjunctivitis (natural history of the disease). | Q45097814 | ||
| Coxsackie virus A24 infection presenting as acute flaccid paralysis | Q45735656 | ||
| Poliomyelitis-like illness due to Japanese encephalitis virus | Q45754905 | ||
| Limb Paralysis as a Manifestation of Coxsackie B Virus Infection | Q45863874 | ||
| An apparently new enterovirus isolated from patients with disease of the central nervous system | Q46144493 | ||
| Enterovirus Type 71 Infections: A Varied Clinical Pattern Sometimes Mimicking Paralytic Poliomyelitis | Q46148425 | ||
| Coxsackie A-9 in the etiology of poliomyelitis-like diseases | Q46698044 | ||
| Enterovirus surveillance--United States, 1970-2005. | Q47186447 | ||
| A virus-like particle vaccine confers protection against enterovirus D68 lethal challenge in mice | Q47237112 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | infectious disease | Q18123741 |
| P304 | page(s) | 34 | |
| P577 | publication date | 2018-06-29 | |
| P1433 | published in | Current infectious disease reports | Q26842136 |
| P1476 | title | Acute Flaccid Paralysis and Enteroviral Infections | |
| P478 | volume | 20 |
| Q96303450 | Acute Flaccid Myelitis in Children in Zhejiang Province, China |
| Q64086006 | Acute Flaccid Myelitis: Something Old and Something New |
| Q64239432 | An increase in reports of acute flaccid paralysis (AFP) in the United Kingdom, 1 January 2018-21 January 2019: early findings |
| Q92798155 | Characteristics of Patients with Acute Flaccid Myelitis, United States, 2015-2018 |
| Q57463615 | Not your usual tRNA synthetase: hWARS serves as an enterovirus entry factor |
| Q97526164 | Pediatric NMOSD: A Review and Position Statement on Approach to Work-Up and Diagnosis |
| Q59351836 | [Neurological complications of infections with (novel) enteroviruses] |
Search more.